Gregor Larbig has been granted 12 US patents while listed as an inventor at Merck . The first was granted in 2013 and the most recent in June 2024. Gregor Larbig ranks #396,045 of 4,157,543 US inventors in our database (top 9.5%). Patent records list Gregor Larbig in Gelnhausen, DE.
Patents per Year Patents granted per year, 2013 to 2024 Bar chart with a peak of 2 patents in 2015. peak 2 2013: 1 patents 2013 2015: 2 patents 2015 2016: 1 patents 2016 2017: 2 patents 2017 2018: 2 patents 2018 2019: 1 patents 2019 2023: 1 patents 2023 2024: 2 patents 2024
Issued Patents All Time
Profile Widget
Showing 1–12 of 12 patents
Patent # Title Co-Inventors Date Approx Value ⓘ
11999893 Dielectric copolymer materials Pawel Miskiewicz 2024-06-04
$167,439,000
11959007 Dielectric materials Frank Meyer , Karsten Koppe 2024-04-16
$245,789,000
11834598 Dielectric copolymer materials Pawel Miskiewicz , Frank Meyer , Joerg Pahnke , Karsten Koppe 2023-12-05
$665,443,000
10413614 Conjugates for protection from nephrotoxic active substances Armin Kuebelbeck , Stefan Arnold , Walter Mier , Uwe Haberkorn 2019-09-17
$91,414,000
10111952 Silicon dioxide nanoparticles and the use thereof for vaccination Markus Weigandt , Andrea Hanefeld , Armin Kuebelbeck 2018-10-30
$258,924,000
10065993 Peptides and peptide/active compound conjugates for renal targeting Armin Kuebelbeck , Stefan Arnold , Walter Mier 2018-09-04
$106,918,000
9808535 Conjugates for protection from nephrotoxic active substances Armin Kuebelbeck , Stefan Arnold , Walter Mier , Uwe Haberkorn 2017-11-07
$37,151,000
9808521 Silicon dioxide nanoparticles and the use thereof for vaccination Markus Weigandt , Andrea Hanefeld , Armin Kuebelbeck 2017-11-07
$37,151,000
9433673 Silicon dioxide nanoparticles and the use thereof for vaccination Markus Weigandt , Andrea Hanefeld , Armin Kuebelbeck 2016-09-06
$101,652,000
9078929 ε-Polylysine conjugates and the use thereof Armin Kuebelbeck , Walter Mier , Barbro Beijer , Uwe Haberkorn 2015-07-14
$88,436,000
8980324 Silicon dioxide nanoparticles and the use thereof for vaccination Markus Weigandt , Andrea Hanefeld , Armin Kuebelbeck 2015-03-17
$59,557,000
8410152 Thiazolhydrazides for treatment of neurodegenerative diseases Eckhard Mandelkow , Eva-Maria Mandelkow , Markus Pickhardt , Jacek Biernat , David George Lloyd +1 more 2013-04-02
